National Vision (EYE) Competitors

National Vision (NASDAQ:EYE) and Axonics (NASDAQ:AXNX) are both consumer staples companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, community ranking, media sentiment, risk, analyst recommendations, institutional ownership, profitability, valuation and earnings.

Does the MarketBeat Community believe in EYE or AXNX?

National Vision received 80 more outperform votes than Axonics when rated by MarketBeat users. However, 66.41% of users gave Axonics an outperform vote while only 65.63% of users gave National Vision an outperform vote.

Company	Underperform	Outperform
National Vision	Outperform Votes 254 65.63%	Underperform Votes 133 34.37%
Axonics	Outperform Votes 174 66.41%	Underperform Votes 88 33.59%

Which has higher earnings & valuation, EYE or AXNX?

Axonics has lower revenue, but higher earnings than National Vision. Axonics is trading at a lower price-to-earnings ratio than National Vision, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
National Vision	$2.18B	0.41	-$65.90M	-$0.20	-57.00
Axonics	$366.38M	9.90	-$6.09M	-$0.12	-591.45

Do analysts recommend EYE or AXNX?

National Vision currently has a consensus price target of $14.00, suggesting a potential upside of 22.81%. Axonics has a consensus price target of $71.00, suggesting a potential upside of 0.03%. Given National Vision's stronger consensus rating and higher probable upside, research analysts clearly believe National Vision is more favorable than Axonics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
National Vision	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33
Axonics	0 Sell rating(s)	8 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Does the media favor EYE or AXNX?

In the previous week, National Vision had 3 more articles in the media than Axonics. MarketBeat recorded 4 mentions for National Vision and 1 mentions for Axonics. National Vision's average media sentiment score of 0.85 beat Axonics' score of 0.00 indicating that National Vision is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
National Vision	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Axonics	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Which has more volatility and risk, EYE or AXNX?

National Vision has a beta of 1.41, indicating that its stock price is 41% more volatile than the S&P 500. Comparatively, Axonics has a beta of 0.82, indicating that its stock price is 18% less volatile than the S&P 500.

Is EYE or AXNX more profitable?

National Vision has a net margin of -0.81% compared to Axonics' net margin of -1.31%. National Vision's return on equity of 3.52% beat Axonics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
National Vision	-0.81%	3.52%	1.39%
Axonics	-1.31%	0.36%	0.31%

Do insiders & institutionals have more ownership in EYE or AXNX?

99.5% of Axonics shares are owned by institutional investors. 2.3% of National Vision shares are owned by insiders. Comparatively, 1.9% of Axonics shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

National Vision beats Axonics on 13 of the 18 factors compared between the two stocks.